HOME >> MEDICINE >> NEWS
Promising drug fails to improve COPD symptoms

NF-, and a number of studies have reported increased production of TNF in COPD patients. This increased production has been linked to weight loss, muscle weakness and muscle loss.

In addition, animal studies supported the prospect using the drug in COPD. When TNF- was infused into rats, they developed emphysema, which, along with chronic bronchitis, makes up most COPD cases. When the TNF- receptor was turned off in mice, they were less likely than mice that had not be genetically altered to develop emphysema when exposed to chronic cigarette smoke.

The latest study, however, did confirm a recently reported pilot study that found no improvement among the 14 COPD patients given infliximab.

In attempting to explain the disappointing results, the study authors speculate that, despite infliximab's efficacy in treating other inflammatory diseases, it may not be effective in COPD because other mediators, in addition to TNF-, are necessary to cause COPD. They also concede that six months may simply be too short a time period to see improvement.

However, an increased number of malignancies observed in infliximab-treated subjects, the authors said, raised concern about the safety of this drug in lung patients. Although the malignancies may have been present when the patients enrolled in the study, "the possibility that infliximab contributed to the progession, and thus the diagnosis, of malignancies remains a serious concern."

This safety issue, coupled with the "resoundingly negative results," make in unlikely that a longer trial will be undertaken, according to the accompanying editorial.


'"/>

Contact: Suzy Martin
smartin@thoracic.org
212-315-8631
American Thoracic Society
1-May-2007


Page: 1 2

Related medicine news :

1. Promising therapy for ALS delivers antisense drug directly to nervous system
2. Promising new treatment for ulcerative colitis sufferers
3. Promising advance in breast cancer research
4. Promising obesity therapy receives follow-on funding
5. Promising diagnostic tools for multiple sclerosis developed at Yale
6. Promising therapies for haemophilia & heart disease
7. Promising new TB drug enters clinical trial
8. Promising new West Nile therapy cures disease in mice
9. Government fails sleepy Judge Dodd
10. Pairing medical therapy with coronary intervention fails to reduce heart disease deaths
11. Community and clinic-based HIV-1 control program fails to decrease incidence of HIV-1 in Zimbabwe

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Promising drug fails improve COPD symptoms

(Date:3/5/2015)... For PASCHA Chocolate, less is more. ... the robust flavor of the cacao bean bursts through ... is free from peanuts, nuts, dairy, soy, eggs, fish, ... 6th- 8th at Expo West., ,    NEW PASCHA ... broken new ground with their New PASCHA Make Me ...
(Date:3/5/2015)... Minn. (PRWEB) March 05, 2015 ... invites healthcare organizations to participate in its 2015 ... data from executive and director-level positions, and the ... , Last year’s report featured data on 60 ... independent children’s healthcare organizations and 7 subsidiary children’s ...
(Date:3/5/2015)... March 05, 2015 Leading nutritional supplement ... week’s Arnold Sports Festival and Arnold Fitness EXPO ... Metabolic Nutrition will host a display booth featuring free ... E.S.P. and its highly-popular, class-leading fat burner Synedrex. The ... unique recipes that utilize its top-of-the-line supplements and miniature ...
(Date:3/5/2015)... Indialantic, FL (PRWEB) March 05, 2015 ... sports nutrition products, is pleased to offer reformulated Millennium ... official website, Millennium 500 is a German grade creatine ... muscle hydration, promote muscle recovery, and aid with overall ... occurring compound that acts as a reserve energy source ...
(Date:3/5/2015)... Jordan Valley Medical Center is now utilizing ... for sudden cardiac arrest. When a patient wears this ... any life-threatening abnormalities. If an abnormal heart rhythm is ... a treatment shock to restore normal rhythm to the ... Medical Center and the Heart and Lung Institute of ...
Breaking Medicine News(10 mins):Health News:PASCHA Allergen Free Organic Chocolate to Appear at Natural Products Expo West March 6-8, 2015 2Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:Nutrition Leaders Offers Reformulated Millennium 500 German Grade Creatine 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 3
(Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... the "India Pharma Outlook 2015: Accelerating growth to ... beyond Generics" report to their offering. ... slump in the 2013 caused by the market,s reaction ... is expected to continue to be healthy, as the ...
(Date:3/5/2015)... N.J. , March 5, 2015  ContraVir Pharmaceuticals, ... focused on the development and commercialization of targeted antiviral ... 27 th Annual ROTH Conference, to be held ... James Sapirstein , Chief ... business during his live presentation and will be available ...
(Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... addition of Jain PharmaBiotech,s new report "Therapeutic ... to their offering. This report ... specialty, aimed at improving patient care by monitoring ... the dose of drugs for improving outcome. TDM ...
Breaking Medicine Technology:India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3ContraVir to Present at 27th Annual ROTH Conference 2Global Therapeutic Drug Monitoring Report 2015 - Technologies, Markets, and Companies Analysis 2014-2024 2
Cached News: